Sign in

CIK 0001175151 · Non-accelerated filer<br>Smaller reporting company

Cytosorbents Corp

Sign in to watch
Ticker
CTSO
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
980373793
Phone
973-329-8885
Business address
305 COLLEGE ROAD EAST, PRINCETON, NJ, 08540
Former names
MedaSorb Technologies CORP, GILDER ENTERPRISES INC
  1. 4 Open-market sale Chief Financial Officer sold 120 shares at $8.25 ($990)
  2. 4 Open-market sale Chief Financial Officer sold 10,000 shares at $8.00 ($80,000)
  3. 8-K Event Material agreement · Other events
  4. 8-K Event Executive or director change
  5. 4 Grant or award Chief Financial Officer acquired 8,800 shares (grant or award)
  6. 4 Grant or award Chief Medical Officer acquired 20,000 shares (grant or award)
  7. 4 Grant or award Chief Operating Officer acquired 10,100 shares (grant or award)
  8. 4 Grant or award President and CEO acquired 10,300 shares (grant or award)
  9. 4 Open-market sale Chief Financial Officer sold 11,176 shares at $8.25 ($92,202)
  10. 4 Open-market sale Chief Financial Officer sold 1,104 shares at $8.25 ($9,108)
  11. 8-K Event Results of operations
  12. 10-K Report Annual Report
  13. 8-K Event Executive or director change
  14. 4 Grant or award Chief Medical Officer acquired 14,000 shares (grant or award)
  15. 4 Grant or award Chief Operating Officer acquired 38,000 shares (grant or award)
  16. 4 Grant or award Chief Financial Officer acquired 34,700 shares (grant or award)
  17. 4 Grant or award President and CEO acquired 43,000 shares (grant or award)
  18. 4 Shares withheld for taxes Chief Operating Officer gave up 35,257 shares (to pay taxes)
  19. 4 Open-market sale Chief Financial Officer sold 12,400 shares at $7.75 ($96,100)
  20. 4 Open-market sale Chief Financial Officer sold 32,400 shares at an average $7.30 ($236,400)

Page 24 of 49 · 978 filings